Your session is about to expire
← Back to Search
Electrophysiology Device
Optical Coherence Tomography (OCT) for Retinal Disease
N/A
Waitlist Available
Research Sponsored by Optos, PLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
This trial is testing a new eye pressure-measuring device against a current one to see how well it works in normal, glaucoma, and retinal disease patients.
Eligible Conditions
- Retinal Disease
- Glaucoma
- Normal
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Medical Devices
Limit of Agreement (LOA) between the P200TE and predicate device measurements of ganglion cell complex thickness (μm).
Optic Disk
+5 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Optical Coherence Tomography (OCT)Experimental Treatment2 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
P200TE
2019
N/A
~370
Predicate Device
2019
N/A
~300
Find a Location
Who is running the clinical trial?
Optos, PLCLead Sponsor
17 Previous Clinical Trials
3,500 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger